Skip to main content
Arecor Therapeutics plc (AIM:AREC)
London flag London · Delayed Price · Currency is GBP · Price in GBX
75.00
+3.00 (4.17%)
Mar 6, 2026, 8:01 AM GMT

Arecor Therapeutics Revenue

Arecor Therapeutics had revenue of 2.00M GBP in the half year ending June 30, 2025, with 20.01% growth. This brings the company's revenue in the last twelve months to 5.06M, up 3.31% year-over-year. In the year 2024, Arecor Therapeutics had annual revenue of 5.05M with 10.50% growth.

Revenue (ttm)
5.06M
Revenue Growth
+3.31%
P/S Ratio
5.37
Revenue / Employee
115.02K
Employees
44
Market Cap
27.18M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20245.05M480.00K10.50%
Dec 31, 20234.57M2.17M90.30%
Dec 31, 20222.40M1.25M107.51%
Dec 31, 20211.16M-540.00K-31.80%
Dec 31, 20201.70M-192.99K-10.21%
Dec 31, 2019 Pro Pro Pro
May 31, 2019 Pro Pro Pro
May 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SkinBioTherapeutics 4.64M
Aptamer Group 1.20M
ImmuPharma -69.96K
Fusion Antibodies 1.60M
Ondine Biomedical 1.18M
hVIVO 54.47M
Faron Pharmaceuticals Oy 1.14M
Oxford BioDynamics 1.10M
Revenue Rankings

Arecor Therapeutics News

More News